Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Atyr Pharma Inc
(NQ:
LIFE
)
1.590
-0.020 (-1.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
537,232
Open
1.640
Bid (Size)
1.570 (10)
Ask (Size)
1.660 (10)
Prev. Close
1.610
Today's Range
1.580 - 1.640
52wk Range
1.080 - 2.450
Shares Outstanding
54,291,754
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 09, 2024
Via
Benzinga
aTyr Pharma to Participate in April Investor Conferences
April 01, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Performance
YTD
+6.35%
+6.35%
1 Month
-18.67%
-18.67%
3 Month
+9.28%
+9.28%
6 Month
+19.55%
+19.55%
1 Year
-17.19%
-17.19%
More News
Read More
3 Penny Stocks That Could Be Multibaggers in the Making: March Edition
March 26, 2024
Via
InvestorPlace
LIFE Stock Earnings: aTyr Pharma Misses EPS for Q4 2023
March 14, 2024
Via
InvestorPlace
Recap: aTyr Pharma Q4 Earnings
March 14, 2024
Via
Benzinga
aTyr Pharma's Earnings Outlook
March 13, 2024
Via
Benzinga
Analyst Expectations for aTyr Pharma's Future
September 21, 2023
Via
Benzinga
The Latest Analyst Ratings for aTyr Pharma
May 23, 2023
Via
Benzinga
aTyr Pharma: Q1 Earnings Insights
May 09, 2023
Via
Benzinga
aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
March 14, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 14, 2024
March 14, 2024
Via
Benzinga
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
February 28, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
February 21, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
The 3 Best Penny Stocks to Buy in February 2024
February 15, 2024
Via
InvestorPlace
aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity
January 29, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor
January 18, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Beat of Life Entertainment's 'Diya Jalao Roshni Lao' Campaign: Lighting Up Lives and Preserving Tradition!
November 13, 2023
Via
IssueWire
Topics
Religion
Exposures
Religion
aTyr Pharma to Present at November Investor Conferences
November 01, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Dosing of First Patient in Phase 2 EFZO-CONNECT™ Study of Efzofitimod in Patients with SSc-ILD
October 31, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
September 11, 2023
From
aTyr Pharma, Inc.
Via
GlobeNewswire
$12M Bet On This Trucking Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
August 02, 2023
Via
Benzinga
aTyr Pharma's Cash Runway Secured till 2026, Despite Lack of Material Catalysts: Oppenheimer Analyst
July 05, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 5, 2023
July 05, 2023
Via
Benzinga
7 Growth Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2023
June 28, 2023
Via
InvestorPlace
3 Stocks and Cryptos With the Highest Potential Returns
May 07, 2023
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.